Reported 5 days ago
Eli Lilly announced a $4.5 billion investment to build a new manufacturing center in Indiana aimed at enhancing drug production efficiency and scaling up experimental medicine manufacturing. The facility, named Lilly Medicine Foundry, is projected to create 400 jobs and could potentially boost output by 400% once operational by late 2027. This initiative supports Lilly's efforts to meet the growing demand for its obesity and neurological disease treatments, contributing to a total capital commitment exceeding $23 billion in the U.S. since 2020.
Source: YAHOO